Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti- Pseudomonas aeruginosa bispecific human monoclonal antibody, in P
Other cells were provided by co-authors or collaborators (SW480 and HT29 were provided by McDade and Longley (QUB)
Potential metabolic effects of allulose (requiring further research): Modest reduction in postprandial glucose levels Possible stimulation of endogenous GLP-1 secretion Potential improvement in insulin sensitivity Reduction in overall caloric intake when substituted for sugar Patients should discuss any dietary modifications with their healthcare provider, particularly when managing diabetes or taking glucose-lowering medications
Guo X, Xu K, Wang L, Ding L, Li W, Zhang X, et al
Shopping & Meal Prep Made Simple One of the biggest challenges on GLP-1 medications is having the right foods available when appetite is low and cooking feels overwhelming
Urbano & Fischer Verlag